This ACPE-accredited continuing education course, built and presented by Prescryptive Health, helps pharmacists evaluate patients for their appropriateness to receive COVID-19 monoclonal antibodies. This course is offered in partnership with the National Community Pharmacists Association (NCPA) with ACPE accreditation provided by Oregon State University College of Pharmacy.
Every pharmacist is eligible to receive 1 hour of ACPE-continuing education credit at no cost once the course and short final exam are completed. This program is supported by the State of Oregon and contains open source documents intended to support pharmacists across all 50 states.
Pharmacists on the frontline of COVID-19: From testing to treatment and prevention
About this course
COVID-19 monoclonal antibody therapy is authorized for both the treatment of and post-exposure prophylaxis in certain individuals. This training covers the following topics:
Teletracking is a federal requirement for all pharmacies by The Department of Health and Human Services (HHS).
To register, email HHS-Protect@teletracking.com and ask for a New Therapeutic Facility Template. Complete the template the best you can and e-mail back to the above address. When your facility gets added, all your users will receive an invitation e-mail to set up their own accounts. Instructions can be found at Introduction (cl-teletracking.com).
You may also call for support at 1-877-570-6903, Press 7 for COVID-19 tracking support.
Communities need pharmacies now more than ever. Your ability to safely and effectively administer monoclonal antibody treatment will help to prevent severe complications that could lead to hospitalizations.
Pharmacies must work with their state health department to be able to order the product, and each state will likely have a different process for involvement.